Literature DB >> 26420768

Impact of the AYA HOPE Comorbidity Index on Assessing Health Care Service Needs and Health Status among Adolescents and Young Adults with Cancer.

Xiao-Cheng Wu1, Pinki K Prasad2, Ian Landry3, Linda C Harlan4, Helen M Parsons5, Charles F Lynch6, Ashley W Smith7, Ann S Hamilton8, Theresa H M Keegan9.   

Abstract

BACKGROUND: Existing comorbidity indices were not developed for adolescent and young adults (AYA) 15 to 39 years of age. The aim of this study was to assess impact of comorbidities on health care service needs and health status among AYA cancer survivors using the newly developed AYA HOPE comorbidity index in comparison with the existing indices.
METHODS: Data on comorbid conditions were obtained from medical records and service needs and health status were from a survey of AYA cancer survivors. Prevalence of comorbidities was based on the AYA HOPE index. Charlson and NCI indices were compared. Multivariable logistic regression was used.
RESULTS: Of the 485 patients, 14.6% had ≥2 comorbidities based on the AYA HOPE Index. Prevalence of mental illness and obesity/overweight, which were not included in existing indices, were 8.2% and 5.8%, respectively. Prevalence of cardiovascular, endocrine, gastrointestinal, and neurologic conditions were higher with the AYA HOPE Index than the other two indices. Forty percent of AYA patients reported service needs, particularly for mental health services (25.2%) and support groups (17.7%). Having ≥2 comorbidities on the AYA index was associated with higher mental health service needs [OR, 2.05; 95% confidence interval (CI), 1.10-3.82] adjusting for demographic and clinical factors. Comorbidities were associated with fair/poor self-reported health status.
CONCLUSION: The AYA HOPE Index is a more comprehensive comorbidity index for AYA cancer patients than existing indices, and the number of comorbidities is associated with service needs and health status. IMPACT: The AYA HOPE index could identify patients' additional service needs early in therapy. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26420768      PMCID: PMC4670595          DOI: 10.1158/1055-9965.EPI-15-0401

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  34 in total

Review 1.  Causes and consequences of comorbidity: a review.

Authors:  R Gijsen; N Hoeymans; F G Schellevis; D Ruwaard; W A Satariano; G A van den Bos
Journal:  J Clin Epidemiol       Date:  2001-07       Impact factor: 6.437

2.  Functional status, health problems, age and comorbidity in primary care patients.

Authors:  M Wensing; E Vingerhoets; R Grol
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

3.  Adolescent and young adult oncology, version 2.2014.

Authors:  Peter F Coccia; Alberto S Pappo; Jessica Altman; Smita Bhatia; Scott C Borinstein; Joseph Flynn; A Lindsay Frazier; Suzanne George; Robert Goldsby; Robert Hayashi; Mary S Huang; Rebecca H Johnson; Lynda Kwon Beaupin; Michael P Link; Kevin C Oeffinger; Kathleen M Orr; Damon Reed; Holly L Spraker; Deborah A Thomas; Margaret von Mehren; Daniel S Wechsler; Kimberly F Whelan; Brad Zebrack; Dorothy A Shead; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2014-01       Impact factor: 11.908

4.  Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  B Gandek; J E Ware; N K Aaronson; G Apolone; J B Bjorner; J E Brazier; M Bullinger; S Kaasa; A Leplege; L Prieto; M Sullivan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

5.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

Authors:  J Ware; M Kosinski; S D Keller
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

6.  Cancer and comorbidity: redefining chronic diseases.

Authors:  K S Ogle; G M Swanson; N Woods; F Azzouz
Journal:  Cancer       Date:  2000-02-01       Impact factor: 6.860

7.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

8.  A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer.

Authors:  S T Fleming; A Rastogi; A Dmitrienko; K D Johnson
Journal:  Med Care       Date:  1999-06       Impact factor: 2.983

9.  Development of a comorbidity index using physician claims data.

Authors:  C N Klabunde; A L Potosky; J M Legler; J L Warren
Journal:  J Clin Epidemiol       Date:  2000-12       Impact factor: 6.437

10.  Adolescent and young adult cancer survival.

Authors:  Denise Riedel Lewis; Nita L Seibel; Ashley Wilder Smith; Margaret R Stedman
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11
View more
  8 in total

1.  Prevalence of Survival Without Major Comorbidities Among Adults Born Prematurely.

Authors:  Casey Crump; Marilyn A Winkleby; Jan Sundquist; Kristina Sundquist
Journal:  JAMA       Date:  2019-10-22       Impact factor: 56.272

2.  Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors.

Authors:  Andrea C Betts; Caitlin C Murphy; L Aubree Shay; Bijal A Balasubramanian; Christine Markham; Marlyn Allicock
Journal:  J Cancer Surviv       Date:  2022-01-08       Impact factor: 4.442

3.  Socioeconomic disparities affect survival in malignant ovarian germ cell tumors in AYA population.

Authors:  Laura V Bownes; Laura L Stafman; Ilan I Maizlin; Matthew Dellinger; Kenneth W Gow; Adam B Goldin; Melanie Goldfarb; Monica Langer; Mehul V Raval; John J Doski; Jed G Nuchtern; Sanjeev A Vasudevan; Elizabeth A Beierle
Journal:  J Surg Res       Date:  2017-10-06       Impact factor: 2.192

4.  Polypharmacy and patterns of prescription medication use among cancer survivors.

Authors:  Caitlin C Murphy; Hannah M Fullington; Carlos A Alvarez; Andrea C Betts; Simon J Craddock Lee; David A Haggstrom; Ethan A Halm
Journal:  Cancer       Date:  2018-04-12       Impact factor: 6.860

Review 5.  Understanding care and outcomes in adolescents and young adult with Cancer: A review of the AYA HOPE study.

Authors:  Ashley Wilder Smith; Theresa Keegan; Ann Hamilton; Charles Lynch; Xiao-Cheng Wu; Stephen M Schwartz; Ikuko Kato; Rosemary Cress; Linda Harlan
Journal:  Pediatr Blood Cancer       Date:  2018-10-07       Impact factor: 3.167

6.  Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors.

Authors:  Sarah L Kerns; Chunkit Fung; Sophie D Fossa; Paul C Dinh; Patrick Monahan; Howard D Sesso; Robert D Frisina; Darren R Feldman; Robert J Hamilton; David Vaughn; Neil Martin; Robert Huddart; Christian Kollmannsberger; Deepak Sahasrabudhe; Shirin Ardeshir-Rouhani-Fard; Lawrence Einhorn; Lois B Travis
Journal:  JNCI Cancer Spectr       Date:  2020-03-20

7.  Prevalence and effects of polypharmacy on overall survival in acute myeloid leukemia.

Authors:  Prajwal Dhakal; Elizabeth Lyden; Kate-Lynn E Muir; Zaid S Al-Kadhimi; Thuy Koll; Lori J Maness; Krishna Gundabolu; Vijaya Raj Bhatt
Journal:  Leuk Lymphoma       Date:  2020-03-11

8.  Chronic Comorbidities Among Survivors of Adolescent and Young Adult Cancer.

Authors:  Chun Chao; Smita Bhatia; Lanfang Xu; Kimberly L Cannavale; F Lennie Wong; Po-Yin Samuel Huang; Robert Cooper; Saro H Armenian
Journal:  J Clin Oncol       Date:  2020-07-16       Impact factor: 44.544

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.